We could not find any results for:
Make sure your spelling is correct or try broadening your search.
By Gavin Lower MELBOURNE--Rio Tinto Ltd. (RIO.AU) has pulled out of an accommodation expansion project for its workers in Australia's remote iron ore-rich Pilbara region, the project's developer...
- Fourth quarter diluted EPS grew 11% on revenue growth of 2.7%; cash from operations totaled $360 million - Full year diluted EPS grew 20% on revenue growth of 2.8%; cash from operations totaled...
MADISON, N.J., Jan. 25 /PRNewswire-FirstCall/ -- Quest Diagnostics Incorporated (NYSE:DGX), the world's leading provider of diagnostic testing, information and services, announced that its Board...
MADISON, N.J., Jan. 19 /PRNewswire-FirstCall/ -- Quest Diagnostics Incorporated (NYSE:DGX), the world's leading provider of diagnostic testing, information and services, announced that it is...
MADISON, N.J., Jan. 11 /PRNewswire-FirstCall/ -- A new blood test that identifies changes in DNA associated with colorectal cancer is now available in the U.S. through Quest Diagnostics...
MADISON, N.J., Jan. 8 /PRNewswire-FirstCall/ -- Quest Diagnostics Incorporated (NYSE:DGX), the world's leading provider of diagnostic testing, information and services, announced today that it...
Quest Diagnostics Health Trends(TM) Report based on results of more than 142,000 patient specimens tested for 2009 H1N1 influenza virus since May 2009 MADISON, N.J., Nov. 20...
MADISON, N.J., Nov. 20 /PRNewswire-FirstCall/ -- Quest Diagnostics Incorporated (the "Company") (NYSE:DGX), the world's leading provider of diagnostic testing, information and services...
Simplexa(TM) molecular RT-PCR test runs on the 3M Integrated Cycler; employs RT-PCR technologies comparable to 2009 H1N1 flu test used by World Health Organization MADISON, N.J., Nov. 18...
MADISON, N.J., Nov. 12 /PRNewswire-FirstCall/ -- Quest Diagnostics Incorporated (the "Company") (NYSE:DGX), the world's leading provider of diagnostic testing, information and services...
Period | Change | Change % | Open | High | Low | Avg. Daily Vol | VWAP | |
---|---|---|---|---|---|---|---|---|
1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | DE |
4 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | DE |
12 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | DE |
26 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | DE |
52 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | DE |
156 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | DE |
260 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | DE |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: 1-888-992-3836 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions